US EditionPublished • loading... • Updated
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin – Ortho Spine News
TAMPERE, Finland, Dec. 15, 2025 /PRNewswire/ — Bioretec Oy (“Bioretec” or the “Company”), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeOs DrillPin. The designation covers the RemeOs DrillPin for fixation of bone fragments in pediatric and adult patients and for the treatment of epi-metaphy…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin – Ortho Spine News
TAMPERE, Finland, Dec. 15, 2025 /PRNewswire/ — Bioretec Oy (“Bioretec” or the “Company”), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeOs DrillPin. The designation covers the RemeOs DrillPin for fixation of bone fragments in pediatric and adult patients and for the treatment of epi-metaphy…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
